Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of anti-inflammatory and analgesic agents. Its structure supports enhanced metabolic stability due to the difluorocyclopropane moiety, making it valuable in optimizing drug candidates for improved bioavailability and target selectivity. Commonly employed in research settings for structure-activity relationship (SAR) studies targeting central nervous system (CNS) therapeutics.